CVS Health Corp
Change company Symbol lookup
Select an option...
CVS CVS Health Corp
$GSPIN S&P INTERNET&CAT
LJPC La Jolla Pharmaceutical Co
NBR Nabors Industries Ltd
GPRO GoPro Inc
DDD 3D Systems Corp
AAPL Apple Inc
ARNC Arconic Inc
AA Alcoa Corp
MU Micron Technology Inc
Go

Health Care : Health Care Providers & Services | Large Cap ValueCompany profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$74.92
Day's Change
-0.43 (-0.57%)
Bid
--
Ask
--
B/A Size
--
Day's High
75.49
Day's Low
74.34
Volume
(Below Average)
Volume:
6,958,418

10-day average volume:
8,520,490
6,958,418

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ADTRAN, Inc. (ADTN)

7:00 pm ET October 21, 2019 (Globe Newswire) Print

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against ADTRAN, Inc. ("ADTRAN" or the "Company") (Nasdaq: ADTN) in the United States District Court for the Southern District of New York on behalf of those who purchased or acquired the securities of ADTRAN between February 28, 2019 through October 9, 2019 (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder.

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company's internal control over financial reporting; (2) as a result, certain E&O reserves had been improperly reported; (3) as a result, the Company's financial results for certain periods were misstated; (4) there would be a pause in shipments to the Company's Latin American customers; and (5) as a result, ADTRAN's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm prior to the December 16, 2019 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com.

Please visit our website at http://www.gme-law.com for more information about the firm.

__GNW8366DE3E__IMG

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.